Mitochondrial myopathies
1Department of Molecular Medicine, Karolinska Institutet, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden.
Acta Physiologica Scandinavica
|June 20, 2001
Summary
Mitochondrial myopathy research has advanced significantly, identifying genetic causes in both mitochondrial DNA (mtDNA) and nuclear genes. Future efforts focus on understanding disease mechanisms and developing treatments for respiratory chain dysfunction.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Mitochondrial myopathy with respiratory chain dysfunction was first described nearly 40 years ago.
- Early diagnostic methods relied on morphology and biochemistry, but etiology and pathogenesis remained unclear.
- A poor correlation existed between laboratory findings and clinical presentation in patients.
Purpose of the Study:
- To investigate the genetic basis of mitochondrial myopathy.
- To understand the role of both mitochondrial DNA (mtDNA) and nuclear genes in respiratory chain biogenesis.
- To improve genotype-phenotype correlations in mitochondrial disorders.
Main Methods:
- Review of historical and recent studies on mitochondrial disorders.
- Identification of pathogenic mutations in both mitochondrial DNA (mtDNA) and nuclear genomes.
- Analysis of genotype-phenotype correlations.
Main Results:
- Pathogenic mutations in both mitochondrial DNA (mtDNA) and nuclear genes causing mitochondrial myopathy have been identified.
- Significant progress has been made in correlating genotypes with clinical phenotypes.
- The necessity of both mtDNA and nuclear genes for respiratory chain function is confirmed.
Conclusions:
- Genetic discoveries have greatly advanced the understanding of mitochondrial myopathy.
- Future research should focus on elucidating pathogenic molecular mechanisms.
- Developing effective treatments for respiratory chain dysfunction is a key future challenge.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
08:48Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Related Concept Videos
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:45Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...